Abstract

Background: Glioma stem-like cells (GSCs) are proposed to be responsible for high resistance in glioblastoma multiforme (GBM) treatment. In order to find new strategies aimed at reducing GSC stemness and improving GBM patient survival, we investigated the effects and mechanism of a histone deacetylases (HDACs) inhibitor, suberoylanilide hydroxamic acid (SAHA), since HDAC activity has been linked to cancer stem-like cell (CSC) abundance and properties. Methods: Human GBM cell lines were plated in serum-free suspension cultures allowed for sphere forming and CSC enrichment. Subsequently, upon SAHA treatment, the stemness markers, cell proliferation, and viability of GSCs as well as cellular apoptosis and senescence were examined in order to clarify whether inhibition of GSCs occurs. Results: We demonstrated that SAHA attenuated cell proliferation and diminished the expression stemness-related markers (CD133 and Bmi1) in GSCs. Furthermore, at high concentrations (more than 5 μM), SAHA triggered apoptosis of GSCs accompanied by increases in both activation of caspase 8- and caspase 9-mediated pathways. Interestingly, we found that a lower dose of SAHA (1 μM and 2.5 μM) inhibited GSCs via cell cycle arrest and induced premature senescence through p53 up-regulation and p38 activation. Conclusion: SAHA induces apoptosis and functions as a potent modulator of senescence via the p38-p53 pathway in GSCs. Our results provide a perspective on targeting GSCs via SAHA treatment, and suggest that SAHA could be used as a potent agent to overcome drug resistance in GBM patients.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalJournal of Biomedical Science
Volume23
Issue number1
DOIs
Publication statusPublished - Nov 18 2016

Fingerprint

Glioma
Stem Cells
Glioblastoma
Cells
Histone Deacetylases
Cell proliferation
Apoptosis
Neoplastic Stem Cells
Chemical activation
Cell Proliferation
vorinostat
Caspase 9
Caspase 8
Cell Aging
Cell culture
Modulators
Cell Cycle Checkpoints
Drug Resistance
Suspensions
Cell Survival

Keywords

  • Apoptosis
  • GBM stem-like cells
  • p38
  • p53
  • Senescence
  • Suberoylanilide hydroxamic acid

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

Suberoylanilide hydroxamic acid represses glioma stem-like cells. / Hsu, Che Chia; Chang, Wen-Chang; Hsu, Tsung-I; Liu, Jr Jiun; Yeh, Shiu Hwa; Wang, Jia-Yi; Liou, Jing-Ping; Ko, Chiung-Yuan; Chang, Kwang Yu; Chuang, Jian-Ying.

In: Journal of Biomedical Science, Vol. 23, No. 1, 18.11.2016, p. 1-12.

Research output: Contribution to journalArticle

@article{32ed8aca87c44ddd95c8b7280689862d,
title = "Suberoylanilide hydroxamic acid represses glioma stem-like cells",
abstract = "Background: Glioma stem-like cells (GSCs) are proposed to be responsible for high resistance in glioblastoma multiforme (GBM) treatment. In order to find new strategies aimed at reducing GSC stemness and improving GBM patient survival, we investigated the effects and mechanism of a histone deacetylases (HDACs) inhibitor, suberoylanilide hydroxamic acid (SAHA), since HDAC activity has been linked to cancer stem-like cell (CSC) abundance and properties. Methods: Human GBM cell lines were plated in serum-free suspension cultures allowed for sphere forming and CSC enrichment. Subsequently, upon SAHA treatment, the stemness markers, cell proliferation, and viability of GSCs as well as cellular apoptosis and senescence were examined in order to clarify whether inhibition of GSCs occurs. Results: We demonstrated that SAHA attenuated cell proliferation and diminished the expression stemness-related markers (CD133 and Bmi1) in GSCs. Furthermore, at high concentrations (more than 5 μM), SAHA triggered apoptosis of GSCs accompanied by increases in both activation of caspase 8- and caspase 9-mediated pathways. Interestingly, we found that a lower dose of SAHA (1 μM and 2.5 μM) inhibited GSCs via cell cycle arrest and induced premature senescence through p53 up-regulation and p38 activation. Conclusion: SAHA induces apoptosis and functions as a potent modulator of senescence via the p38-p53 pathway in GSCs. Our results provide a perspective on targeting GSCs via SAHA treatment, and suggest that SAHA could be used as a potent agent to overcome drug resistance in GBM patients.",
keywords = "Apoptosis, GBM stem-like cells, p38, p53, Senescence, Suberoylanilide hydroxamic acid",
author = "Hsu, {Che Chia} and Wen-Chang Chang and Tsung-I Hsu and Liu, {Jr Jiun} and Yeh, {Shiu Hwa} and Jia-Yi Wang and Jing-Ping Liou and Chiung-Yuan Ko and Chang, {Kwang Yu} and Jian-Ying Chuang",
year = "2016",
month = "11",
day = "18",
doi = "10.1186/s12929-016-0296-6",
language = "English",
volume = "23",
pages = "1--12",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Suberoylanilide hydroxamic acid represses glioma stem-like cells

AU - Hsu, Che Chia

AU - Chang, Wen-Chang

AU - Hsu, Tsung-I

AU - Liu, Jr Jiun

AU - Yeh, Shiu Hwa

AU - Wang, Jia-Yi

AU - Liou, Jing-Ping

AU - Ko, Chiung-Yuan

AU - Chang, Kwang Yu

AU - Chuang, Jian-Ying

PY - 2016/11/18

Y1 - 2016/11/18

N2 - Background: Glioma stem-like cells (GSCs) are proposed to be responsible for high resistance in glioblastoma multiforme (GBM) treatment. In order to find new strategies aimed at reducing GSC stemness and improving GBM patient survival, we investigated the effects and mechanism of a histone deacetylases (HDACs) inhibitor, suberoylanilide hydroxamic acid (SAHA), since HDAC activity has been linked to cancer stem-like cell (CSC) abundance and properties. Methods: Human GBM cell lines were plated in serum-free suspension cultures allowed for sphere forming and CSC enrichment. Subsequently, upon SAHA treatment, the stemness markers, cell proliferation, and viability of GSCs as well as cellular apoptosis and senescence were examined in order to clarify whether inhibition of GSCs occurs. Results: We demonstrated that SAHA attenuated cell proliferation and diminished the expression stemness-related markers (CD133 and Bmi1) in GSCs. Furthermore, at high concentrations (more than 5 μM), SAHA triggered apoptosis of GSCs accompanied by increases in both activation of caspase 8- and caspase 9-mediated pathways. Interestingly, we found that a lower dose of SAHA (1 μM and 2.5 μM) inhibited GSCs via cell cycle arrest and induced premature senescence through p53 up-regulation and p38 activation. Conclusion: SAHA induces apoptosis and functions as a potent modulator of senescence via the p38-p53 pathway in GSCs. Our results provide a perspective on targeting GSCs via SAHA treatment, and suggest that SAHA could be used as a potent agent to overcome drug resistance in GBM patients.

AB - Background: Glioma stem-like cells (GSCs) are proposed to be responsible for high resistance in glioblastoma multiforme (GBM) treatment. In order to find new strategies aimed at reducing GSC stemness and improving GBM patient survival, we investigated the effects and mechanism of a histone deacetylases (HDACs) inhibitor, suberoylanilide hydroxamic acid (SAHA), since HDAC activity has been linked to cancer stem-like cell (CSC) abundance and properties. Methods: Human GBM cell lines were plated in serum-free suspension cultures allowed for sphere forming and CSC enrichment. Subsequently, upon SAHA treatment, the stemness markers, cell proliferation, and viability of GSCs as well as cellular apoptosis and senescence were examined in order to clarify whether inhibition of GSCs occurs. Results: We demonstrated that SAHA attenuated cell proliferation and diminished the expression stemness-related markers (CD133 and Bmi1) in GSCs. Furthermore, at high concentrations (more than 5 μM), SAHA triggered apoptosis of GSCs accompanied by increases in both activation of caspase 8- and caspase 9-mediated pathways. Interestingly, we found that a lower dose of SAHA (1 μM and 2.5 μM) inhibited GSCs via cell cycle arrest and induced premature senescence through p53 up-regulation and p38 activation. Conclusion: SAHA induces apoptosis and functions as a potent modulator of senescence via the p38-p53 pathway in GSCs. Our results provide a perspective on targeting GSCs via SAHA treatment, and suggest that SAHA could be used as a potent agent to overcome drug resistance in GBM patients.

KW - Apoptosis

KW - GBM stem-like cells

KW - p38

KW - p53

KW - Senescence

KW - Suberoylanilide hydroxamic acid

UR - http://www.scopus.com/inward/record.url?scp=84995610477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995610477&partnerID=8YFLogxK

U2 - 10.1186/s12929-016-0296-6

DO - 10.1186/s12929-016-0296-6

M3 - Article

C2 - 27863490

VL - 23

SP - 1

EP - 12

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

ER -